Correlation Between Oric Pharmaceuticals and Molecular Partners
Can any of the company-specific risk be diversified away by investing in both Oric Pharmaceuticals and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oric Pharmaceuticals and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oric Pharmaceuticals and Molecular Partners AG, you can compare the effects of market volatilities on Oric Pharmaceuticals and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oric Pharmaceuticals with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oric Pharmaceuticals and Molecular Partners.
Diversification Opportunities for Oric Pharmaceuticals and Molecular Partners
-0.29 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Oric and Molecular is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Oric Pharmaceuticals and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Oric Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oric Pharmaceuticals are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Oric Pharmaceuticals i.e., Oric Pharmaceuticals and Molecular Partners go up and down completely randomly.
Pair Corralation between Oric Pharmaceuticals and Molecular Partners
Given the investment horizon of 90 days Oric Pharmaceuticals is expected to generate 0.72 times more return on investment than Molecular Partners. However, Oric Pharmaceuticals is 1.39 times less risky than Molecular Partners. It trades about 0.15 of its potential returns per unit of risk. Molecular Partners AG is currently generating about -0.06 per unit of risk. If you would invest 844.00 in Oric Pharmaceuticals on August 25, 2024 and sell it today you would earn a total of 115.00 from holding Oric Pharmaceuticals or generate 13.63% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oric Pharmaceuticals vs. Molecular Partners AG
Performance |
| Timeline |
| Oric Pharmaceuticals |
| Molecular Partners |
Oric Pharmaceuticals and Molecular Partners Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oric Pharmaceuticals and Molecular Partners
The main advantage of trading using opposite Oric Pharmaceuticals and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oric Pharmaceuticals position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.| Oric Pharmaceuticals vs. Seer Inc | Oric Pharmaceuticals vs. Anebulo Pharmaceuticals | Oric Pharmaceuticals vs. Cullinan Oncology LLC | Oric Pharmaceuticals vs. C4 Therapeutics |
| Molecular Partners vs. Eliem Therapeutics | Molecular Partners vs. HCW Biologics | Molecular Partners vs. RenovoRx | Molecular Partners vs. Scpharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |